Moderna

📍 Cambridge, United States🗓 Founded 2010👥 7,025 employees💰 Last funded Feb 2020
At Moderna, we believe messenger RNA, or mRNA, is the “software of life.” Every cell in the body uses mRNA to provide real-time instructions to make the proteins necessary to drive all aspects of biology, including in human health and disease. Given its essential role, we believe mRNA could be used to create a new category of medicines with significant potential to improve the lives of patients. We are pioneering a new class of medicines made of messenger RNA, or mRNA. The potential implications of using mRNA as a drug are significant and far-reaching and could meaningfully improve how medicines are discovered, developed and manufactured. To learn more, visit www.modernatx.com. This Moderna page is not the appropriate place to report adverse events (side-effects) for any products. If you are or someone you know is experiencing a side effect, please reach out to your healthcare professional. Moderna is continuously monitoring the safety of its products. We encourage you to report any side effects directly to us at 1‑866‑MODERNA (1‑866‑663‑3762).
6
Total investors
1
Early stage
0
Mid stage
3
Late stage
2010
Founded
Investor geography2 countries
United States
4
United Kingdom
1
Investor activity2003–2020 · investors recorded per year
20031201822019120202
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Moderna?
Moderna has 6 investors on record on gritt.io, including 1 early-stage backers and 3 late-stage investors.
When did Moderna last raise funding?
The most recent investment in Moderna recorded on gritt.io was in February 2020.
When was Moderna founded?
Moderna was founded in 2010.
What industry is Moderna in?
Moderna operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Moderna based?
Moderna is headquartered in Cambridge, United States.